The next challenge will be integrating the multiple facets of TERT regulation and removing the ambiguity of isoform-level RNA sequencing while sustaining the large-scale feasibility necessary to uncover cell-type specific nuances and novel cancer therapeutic strategies. This evidence concerns the gene TERT and cancer.